Consolidated Balance Sheet March 31, 212 ASSETS CURRENT ASSETS: Cash and cash equivalents (Notes 8 and 19) Time deposits over three months (Note 19) Receivables (Note 19): Trade notes (Note 11) Trade accounts Other Marketable securities (Notes 4 and 19) Inventories (Note 5) Advance payments Deferred tax assets (Note 16) Prepaid expenses and other current assets Allowance for doubtful accounts current assets 212 211 175,956 131,662 789 82 2,725 2,936 47,672 49,54 4,147 5,474 218 94 1,459 9,458 23,789 16,823 12,92 15,84 4,897 3,975 (2,354) (2,262) 722,223 611,67 212 $ 2,14,849 9,611 252,171 5,726,634 5,465 2,655 127,265 289,443 157,25 59,582 (28,646) 8,787,237 PROPERTY, PLANT AND EQUIPMENT (Notes 6 and 7): Land 16,732 16,379 1,955,624 Buildings and structures 157,78 155,994 1,918,828 Other 28,52 27,475 347,1 346,961 343,848 4,221,454 Accumulated depreciation (14,458) (1,271) (1,27,943) Net property, plant and equipment 242,52 243,577 2,95,511 INVESTMENTS AND OTHER ASSETS (Note 7): Investment securities (Notes 4 and 19) 9,623 67,862 1,12,66 Investments in unconsolidated subsidiaries and affiliated companies (Note 2) 24,921 88,939 33,212 Goodwill 44,339 32,853 539,471 Intangible assets 18,752 2,327 228,158 Deferred tax assets (Note 16) 23,75 32,27 288,964 Other assets 38,825 39,168 472,383 Allowance for doubtful accounts (3,784) (3,198) (46,46) Allowance for losses on investment securities and investments in unconsolidated subsidiaries (257) (16) (3,128) investments and other assets 237,169 278,115 2,885,623 TOTAL 1,21,894 1,133,3 $14,623,372 Consolidated Balance Sheet - 1/2 Dentsu Annual Report 212
LIABILITIES AND EQUITY CURRENT LIABILITIES: Short-term borrowings (Notes 8 and 19) Current portion of long-term debt (Notes 8, 18 and 19) Payables (Note 19): Trade notes (Note 11) Trade accounts (Note 8) Other Income taxes payable Accrued expenses Asset retirement obligations Other current liabilities current liabilities 212 211 4,733 25,62 9,689 44,431 9,277 13,629 29,4 28,397 525,181 3,138 19,823 1,986 368,388 8,59 11,412 28,519 53 28,592 478,975 212 $ 57,589 311,728 117,888 4,92,693 112,877 165,829 357,719 4 345,512 6,389,842 LONG-TERM LIABILITIES: Long-term debt (Notes 8, 18 and 19) 57,176 81,72 695,659 Accrued pension and severance costs (Note 9) 38,24 33,839 464,829 Deferred tax liabilities (Note 16) 26 41 32 Deferred tax liabilities on land revaluation difference (Notes 2.l and 16) 9,38 1,293 19,968 Asset retirement obligations 851 784 1,362 Other long-term liabilities 14,527 16,151 176,756 long-term liabilities 119,824 142,183 1,457,897 COMMITMENTS AND CONTINGENT LIABILITIES (Notes 18, 21 and 22) EQUITY (Note 12): Common stock, authorized, 1,1,, shares; issued, 278,184, shares in 212 and 211 58,967 58,967 717,448 Capital surplus 6,899 6,899 74,956 Retained earnings 487,133 468,846 5,926,917 Treasury stock at cost, 29,32,96 shares in 212 and 29,29,88 shares in 211 (65,7) (65,64) (791,77) Accumulated other comprehensive income: Unrealized gain on available-for-sale securities 12,135 1,93 147,654 Deferred loss on derivatives under hedge accounting (453) (2,823) (5,516) Land revaluation difference (Note 2.l ) (5,931) (7,187) (72,17) Foreign currency translation adjustments (11,389) (22,634) (138,572) 536,29 492,933 6,525,1 Minority interests 2,598 19,28 25,622 equity 556,889 512,141 6,775,632 TOTAL 1,21,894 1,133,3 $14,623,372 Consolidated Balance Sheet - 2/2 Dentsu Annual Report 212
Consolidated Statement of Income Year ended March 31, 212 NET SALES COST OF SALES Gross profit SELLING, GENERAL AND ADMINISTRATIVE EXPENSES (Note 17) Operating income 212 211 1,893,55 1,833,449 1,56,248 1,515,753 332,87 317,696 28,829 266,758 51,977 5,937 212 $23,32,677 18,983,433 4,49,243 3,416,831 632,411 OTHER INCOME (EXPENSES) (Note 3): Interest and dividend income 2,442 2,246 29,718 Interest expense (1,929) (2,131) (23,479) Profit distributions 2,71 733 25,197 Equity in earnings of affiliated companies 8,35 4,329 11,5 Gain on sales of investment securities 6,757 1,567 82,221 Loss on transfer of business (Note 14) (4,56) (55,489) Other net (Notes 7 and 14) (6,64) (22,32) (8,357) Other income (expenses) net 6,481 (15,557) 78,861 INCOME BEFORE INCOME TAXES AND MINORITY INTERESTS 58,459 35,379 711,272 INCOME TAXES (Note 16): Current (19,735) 15,17 (24,122) Deferred (7,218) (2,74) (87,829) income taxes (26,954) 12,466 (327,951) NET INCOME BEFORE MINORITY INTERESTS 31,55 22,913 383,321 MINORITY INTERESTS IN NET INCOME 1,932 1,277 23,57 NET INCOME 29,573 21,635 $ 359,813 Yen PER SHARE OF COMMON STOCK (Notes 2.w and 24): Basic net income Diluted net income Cash dividends applicable to the year 212 211 118.69 114.81 31. 86.84 83.28 29.5 212 $ 1.44 1.4.38 Consolidated Statement of Income Dentsu Annual Report 212
Consolidated Statement of Comprehensive Income Year ended March 31, 212 NET INCOME BEFORE MINORITY INTERESTS OTHER COMPREHENSIVE INCOME (Note 23): Unrealized gain on available-for-sale securities Deferred gain (loss) on derivatives under hedge accounting Foreign currency translation adjustments Share of other comprehensive income in associates other comprehensive income COMPREHENSIVE INCOME (Note 23) TOTAL COMPREHENSIVE INCOME ATTRIBUTABLE TO (Note 23): Owners of the parent Minority interests 212 211 31,55 22,913 1,194 944 2,378 (1,937) (4,21) (5,433) 15,287 199 23,839 (6,227) 55,344 16,686 53,393 15,495 1,951 1,191 212 $383,321 124,37 28,935 (48,929) 186,7 29,49 $673,37 $649,632 23,738 Consolidated Statement of Comprehensive Income Dentsu Annual Report 212
Consolidated Statement of Changes in Equity Year ended March 31, 212 Accumulated Other Comprehensive Income Outstanding Number of Shares of Common Common Capital Surplus Retained Earnings Treasury Unrealized Gain on Available-for-sale Securities Deferred Loss on Derivatives under Hedge Accounting Land Revaluation Difference Foreign Currency Translation Adjustments Minority Interests Equity BALANCE, APRIL 1, 21 249,157,722. 58,967 6,899 454,14 (65,56) 737 (886) (7,187) (17,237) 484,25 21,36 55,556 Net income 21,635 21,635 21,635 Cash dividends, 29. per share Change in scope of consolidation (2) (2) (2) Change in scope of equity method 424 424 424 Repurchase of treasury stock (3,989.) Disposal of treasury stock 459. () 1 1 1 Transfer to retained earnings from other capital surplus () Other changes in the year 1,192 (1,936) (5,396) (6,14) (2,98) (8,238) BALANCE, MARCH 31, 211 249,154,192. 58,967 6,899 468,846 (65,64) 1,93 (2,823) (7,187) (22,634) 492,933 19,28 512,141 Net income 29,573 29,573 29,573 Cash dividends, 3. per share Reversal of revaluation reserve for land () () () Change in scope of consolidation 413 413 413 Change in scope of equity method (4,225) (4,225) (4,225) Repurchase of treasury stock (2,411.) Disposal of treasury stock 123. () Transfer to retained earnings from other capital surplus () Other changes in the year 1,25 2,369 1,255 11,244 25,75 1,39 26,466 BALANCE, MARCH 31, 212 249,151,94. 58,967 6,899 487,133 (65,7) 12,135 (453) (5,931) (11,389) 536,29 2,598 556,889 Accumulated Other Comprehensive Income Common Capital Surplus Retained Earnings Treasury Unrealized Gain on Available-for-sale Securities Deferred Loss on Derivatives under Hedge Accounting Land Revaluation Difference Foreign Currency Translation Adjustments Minority Interests Equity BALANCE, MARCH 31, 211 $717,448 $74,956 $5,74,423 $(791,64) $ 23,483 $ (34,35) $(87,446) $(275,386) $5,997,488 $233,72 $ 6,231,19 Net income 359,813 359,813 359,813 Cash dividends, $.37 per share (9,943) (9,943) (9,943) Reversal of revaluation reserve for land (1) (1) (1) Change in scope of consolidation 5,36 5,36 5,36 Change in scope of equity method (51,41) (51,41) (51,41) Repurchase of treasury stock (7) (7) (7) Disposal of treasury stock () 3 3 3 Transfer to retained earnings from other capital surplus () Other changes in the year 124,17 28,833 15,275 136,814 35,94 16,919 322,13 BALANCE, MARCH 31, 212 $717,448 $74,956 $5,926,917 $(791,77) $147,654 $ (5,516) $(72,17) $(138,572) $6,525,1 $25,622 $6,775,632 Consolidated Statement of Changes in Equity Dentsu Annual Report 212
Consolidated Statement of Cash Flows Year ended March 31, 212 OPERATING ACTIVITIES: Income before income taxes and minority interests Adjustments for: Income taxes paid Depreciation and amortization Impairment loss Amortization of goodwill net Foreign exchange (gain) loss net Equity in earnings of affiliated companies Loss on transfer of business Increase in notes and accounts receivable trade (Increase) decrease in inventories Increase in notes and accounts payable trade Increase in allowance for doubtful accounts Increase in liability for retirement benefits (Increase) decrease in other current assets Increase (decrease) in other current liabilities Other net adjustments Net cash provided by operating activities INVESTING ACTIVITIES: Proceeds from sales of marketable securities Payments for purchases of property, plant and equipment Proceeds from sales of property, plant and equipment Payments for purchases of investment securities Proceeds from sales of investment securities Payments for purchases of software Payments for loans Proceeds from collection of loans Payment for the purchase of consolidated subsidiaries Payment for the purchase of investment in subsidiaries resulting in change in scope of consolidation (Note 15) Proceed from the purchase of investment in subsidiaries resulting in change in scope of consolidation Payments for sales of investments in subsidiaries resulting in change in scope of consolidation Proceeds from sales of investment in subsidiaries resulting in change in scope of consolidation Payments for purchases of long-term prepaid expenses Other net Net cash used in investing activities FINANCING ACTIVITIES: Increase in short-term borrowings net Repayments of long-term debt Payments for repurchase of treasury stock Dividends paid to shareholders Dividends paid to minority shareholders Other net Net cash used in financing activities FOREIGN CURRENCY TRANSLATION ADJUSTMENTS ON CASH AND CASH EQUIVALENTS NET INCREASE IN CASH AND CASH EQUIVALENTS CASH AND CASH EQUIVALENTS, BEGINNING OF YEAR CASH AND CASH EQUIVALENTS OF NEWLY CONSOLIDATED SUBSIDIARIES CASH AND CASH EQUIVALENTS, END OF YEAR 58,459 212 211 (18,55) 14,251 1,74 2,445 (57) (8,35) 4,56 (58,249) (1,342) 33,347 58 4,27 (1,645) 5,24 (62) (32,62) 26,397 (5,458) 38 (7,497) 81,19 (4,14) (29) 1,8 (12,33) (4,22) (339) (3,31) 886 45,941 71 (2,48) (548) 44 (27,331) (1,866) 43,14 131,662 1,152 175,956 35,379 (1,665) 15,485 3,66 1,796 772 (4,329) (12,666) 1,74 15,955 2,391 1,191 12,64 (11,485) 12,83 37,535 72,914 13 (2,345) 42 (2,327) 29,791 (3,662) (2,474) 433 (14,737) (415) 5 (2,82) (3,328) (1,825) 55 (2,346) (1,471) (341) (29,339) (2,969) 38,781 92,854 26 131,662 212 $ 711,272 (225,155) 173,398 13,78 29,758 (696) (11,5) 55,489 (78,72) (16,336) 45,732 6,187 51,963 (129,523) 63,318 (7,543) (39,97) 321,175 6 (66,41) 467 (91,216) 987,838 (5,374) (2,548) 12,264 (146,415) (51,127) (4,127) (4,174) 1,783 558,964 8,529 (243,923) (7) (9,943) (6,671) 536 (332,541) (22,76) 524,89 1,61,931 14,27 $2,14,849 Consolidated Statement of Cash Flows Dentsu Annual Report 212